Correlation Between Altria and Entero Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Altria and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altria and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Altria Group and Entero Therapeutics,, you can compare the effects of market volatilities on Altria and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altria with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altria and Entero Therapeutics,.

Diversification Opportunities for Altria and Entero Therapeutics,

-0.37

Correlation Coefficient

Altria  Entero Therapeutics,

Very good diversification

The 3 months correlation between Altria and Entero is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Altria Group and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Altria is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altria Group are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Altria i.e., Altria and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between Altria and Entero Therapeutics,

Allowing for the 90-day total investment horizon Altria Group is expected to generate 0.18 times more return on investment than Entero Therapeutics,. However, Altria Group is 5.52 times less risky than Entero Therapeutics,. It trades about 0.06 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.01 per unit of risk. If you would invest  4,899  in Altria Group on October 25, 2024 and sell it today you would earn a total of  223.00  from holding Altria Group or generate 4.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Altria Group  vs.  Entero Therapeutics,

Altria Group

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Altria Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Altria is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Entero Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Entero Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Entero Therapeutics, is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Altria and Entero Therapeutics,

The main advantage of trading using opposite Altria and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altria position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.

The idea behind Altria Group and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.